Bridgewater Wealth & Financial Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-6,818
Closed -$417K 83
2017
Q2
$417K Buy
6,818
+1,082
+19% +$65.9K 0.14% 70
2017
Q1
$348K Sell
5,736
-59
-1% -$3.58K 0.13% 72
2016
Q4
$326K Buy
5,795
+425
+8% +$24.9K 0.12% 76
2016
Q3
$320K Buy
5,370
+766
+17% +$44.8K 0.12% 75
2016
Q2
$253K Buy
4,604
+6
+0.1% +$319 0.09% 96
2016
Q1
$232K Buy
+4,598
New +$225K 0.08% 101
2015
Q1
Sell
-4,269
Closed -$231K 88
2014
Q4
$231K Buy
+4,269
New +$238K 0.09% 91

Other funds holding MRK

Bridgewater Wealth & Financial Management's MRK Position: Q3 2017 in Review

Bridgewater Wealth & Financial Management sold out of Merck (MRK) in Q3 2017, closing a stake of 6,818 shares — an estimated $417K sold.

Bridgewater Wealth & Financial Management first reported a position in MRK in Q4 2014 and held it in 7 quarters. The position peaked at $417K in Q2 2017. 1,923 funds tracked by Wall St. Rank hold MRK as of Q3 2017.

  • Bridgewater Wealth & Financial Management reported no remaining Merck position as of Q3 2017 after selling out during the quarter.
  • Bridgewater Wealth & Financial Management sold 6,818 Merck shares in Q3 2017, an estimated $417K.
  • Bridgewater Wealth & Financial Management first reported a position in Merck in Q4 2014 and held it in 7 quarters.
  • Bridgewater Wealth & Financial Management's Merck position peaked at $417K in Q2 2017.
  • 1,923 funds tracked by Wall St. Rank held Merck as of Q3 2017.

Based on Bridgewater Wealth & Financial Management's 13F filing for Q3 2017, filed 14 Nov 2017.